BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23832740)

  • 1. TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer.
    Vázquez PF; Carlini MJ; Daroqui MC; Colombo L; Dalurzo ML; Smith DE; Grasselli J; Pallotta MG; Ehrlich M; Bal de Kier Joffé ED; Puricelli L
    Clin Exp Metastasis; 2013 Dec; 30(8):993-1007. PubMed ID: 23832740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
    Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
    Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
    Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
    Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism between HTRA3 and TGFβ1 Contributes to Metastasis in Non-Small Cell Lung Cancer.
    Zhao J; Feng M; Liu D; Liu H; Shi M; Zhang J; Qu J
    Cancer Res; 2019 Jun; 79(11):2853-2864. PubMed ID: 30940659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer.
    Lin G; Sun L; Wang R; Guo Y; Xie C
    J Thorac Oncol; 2014 Feb; 9(2):170-8. PubMed ID: 24419413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway.
    Fei F; Li X; Xu L; Li D; Zhang Z; Guo X; Yang H; Chen Z; Xing J
    Ann Surg Oncol; 2014 Dec; 21(13):4359-68. PubMed ID: 25084765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
    J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
    Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer.
    Shi C; Xu L; Tang Z; Zhang W; Wei Y; Ni J; Zhang S; Feng J
    Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2.
    Fang F; Zheng Q; Zhang J; Dong B; Zhu S; Huang X; Wang Y; Zhao B; Li S; Xiong H; Chen J; Wu N; Song SW; Chang C; Yang Y
    Oncol Rep; 2013 Jan; 29(1):297-305. PubMed ID: 23129017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.
    Stojsic J; Stankovic T; Stojkovic S; Milinkovic V; Dinic J; Milosevic Z; Milovanovic Z; Tanic N; Bankovic J
    Exp Mol Pathol; 2015 Feb; 98(1):27-32. PubMed ID: 25449334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
    Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
    Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POM121 promotes proliferation and metastasis in non-small-cell lung cancer through TGF-β/SMAD and PI3K/AKT pathways.
    Guan L; Zhang L; Wang T; Jia L; Zhang N; Yan H; Zhao K
    Cancer Biomark; 2021; 32(3):293-302. PubMed ID: 34151840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot characterization of human lung NSCLC by protein pathway activation mapping.
    Zupa A; Improta G; Silvestri A; Pin E; Deng J; Aieta M; Musto P; Nitti D; Mammano E; Liotta L; Belluco C; Wulfkuhle J; Petricoin E
    J Thorac Oncol; 2012 Dec; 7(12):1755-1766. PubMed ID: 23154546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
    Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
    Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of annexin II expression in non-small cell lung cancer.
    Luo CH; Liu QQ; Zhang PF; Li MY; Chen ZC; Liu YF
    Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.
    Zhang W; Guo N; Yu C; Wang H; Zhang Y; Xia H; Yu J; Lu J
    Tumour Biol; 2012 Dec; 33(6):2209-16. PubMed ID: 22890830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.
    Bian Y; Terse A; Du J; Hall B; Molinolo A; Zhang P; Chen W; Flanders KC; Gutkind JS; Wakefield LM; Kulkarni AB
    Cancer Res; 2009 Jul; 69(14):5918-26. PubMed ID: 19584284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.